Peripheral Neuropathy Screening Necessary for Non-Diabetic Adults

MURFREESBORO, Tenn. - June 23, 2021 - PRLog -- Testing for peripheral neuropathy has been a common practice for those who suffer from diabetes. However, a recent study that included both people who have been diagnosed with diabetes and others who don't have that disease has provided medical insights on the implications of loss of feeling.

Data from the Health and Nutrition Examination Survey published in the Annals of Internal Medicine in December 2020 (one of several such studies) shows a clear correlation between peripheral neuropathy and mortality rates. The kicker with this study is the consultion that association of early death with tactile dysfunction isn't limited to those who have diabetes.

That's right, a loss of the sense of feeling in your hands, feet as measured using monofilament testing and other sensory evaluation techniques may be a prediction of early death.

The author of this specific study stated the findings this way, "PN [peripheral neuropathy] may be an underrecognized risk factor for death".

Based upon the unexpected conclusions of this survey (i.e. peripheral neuropathy is a risk factor independent of whether the person who experiences it has diabetes), it may soon be recommended by healthcare researchers that health practitioners routinely perform sensory evaluation tests using monofilament tests or similar PN screening products. However, at this time it is unclear how to treat peripheral neuropathy in people who don't suffer from diabetes, as the specific causes of the loss of tactile sensitivity are unclear.

Monofilament Tests: https://www.prohealthcareproducts.com/monofilament-tests/
Sensory Evaluation: https://www.prohealthcareproducts.com/sensory-evaluation/